Core Outcome Measures in Effectiveness Trials

COS Uptake

It is important to assess the uptake and use of COS in clinical trials, and other research, in order to avoid the development of these COS contributing to the research waste which their development aims to reduce. Assessing uptake can also highlight the benefits of measuring and reporting COS in trials while allowing review and feedback to ensure ongoing relevance, and removal of barriers and facilitators to uptake. Here we list organisations that actively endorse the use of COS and the COMET database.

Trialists


Trial Funders


Trial Registries


Regulatory Authorities


Systematic Review Groups


Clinical Guideline Development Groups


Journal Editors


Other


COS Collaborative Groups

The site uses cookies, some may have been set already. Please refer to our privacy policy & cookie usage statement.
If you continue to use the site we'll assume you're happy to accept the cookies.